EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

HCV Cascade of Care in HIV/HCV Co-Infected Individuals: Missed Opportunities for Micro-Elimination

Christos Thomadakis iD, Dimitrios Basoulis iD, Olga Tsachouridou, Konstantinos Protopapas iD, Vasilios Paparizos, Myrto Astriti, Maria Chini, Georgios Chrysos, Markos Marangos, Periklis Panagopoulos, Diamantis Kofteridis iD, Helen Sambatakou iD und 6 weitere

Viruses · 2024

DOI: 10.3390/v16060885 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Viruses, 2024. Verfasst von Christos Thomadakis und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, 115 27 Athens, Greece. Hauptthemen laut MEDLINE: HIV Infections, Coinfection, Antiviral Agents, Hepatitis C. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gilead Sciences (Hellas), Gilead Sciences Hellas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

People living with HIV-HCV co-infection comprise a target group for HCV-micro-elimination. We conducted an HCV cascade of care (CoC) for HIV-HCV co-infected individuals living in Greece and investigated factors associated with different HCV-CoC stages. We analyzed data from 1213 participants from the Athens Multicenter AIDS Cohort Study. A seven-stage CoC, overall and by subgroup (people who inject drugs (PWID), men having sex with men (MSM), men having sex with women (MSW), and migrants], was constructed, spanning from HCV diagnosis to sustained virologic response (SVR). Logistic/Cox regression models were employed to identify factors associated with passing through each CoC step. Among 1213 anti-HCV-positive individuals, 9.2% died before direct-acting antiviral (DAA) availability. PWID exhibited higher mortality rates than MSM. Of 1101 survivors, 72.2% remained in care and underwent HCV-RNA testing. Migrants and PWID showed the lowest retention rates. HCV-RNA was available for 79.2% of those in care, with 77.8% diagnosed with chronic HCV. Subsequently, 71% initiated DAAs, with individuals with very low CD4 counts (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsCoinfectionAntiviral AgentsHepatitis CHepacivirusHumansMaleFemaleAdultGreeceMiddle AgedSustained Virologic ResponseHomosexuality, MaleHepatitis C, ChronicCohort StudiesSexual and Gender Minorities

Stichwörter der Autor:innen

DAAsHCV micro-eliminationHIV/HCV co-infectioncascade of care (COC)missed opportunities

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, 115 27 Athens, Greece.
  • 1st Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, 115 27 Athens, Greece.
  • Infectious Diseases Unit, 1st Internal Medicine Department, AHEPA University Hospital, Aristotle University of Thessaloniki, 546 36 Thessaloniki, Greece.
  • 4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Attikon University General Hospital, 124 62 Athens, Greece.
  • AIDS Unit, Clinic of Venereologic & Dermatologic Diseases, Medical School, Syngros Hospital, National and Kapodistrian University of Athens, 161 21 Athens, Greece.
  • 1st Department of Internal Medicine and Infectious Diseases Unit, General Hospital of Athens G. Gennimatas, 115 27 Athens, Greece.

ORCID-Profile: Christos Thomadakis, Dimitrios Basoulis, Konstantinos Protopapas, Diamantis Kofteridis, Helen Sambatakou, Nikos Panatzis, Evmorfia Pechlivanidou, Giota Touloumi

Förderung

  • Gilead Sciences (Hellas)
  • Gilead Sciences Hellas

Zitieren

APA

Thomadakis, C., Basoulis, D., Tsachouridou, O., Protopapas, K., Paparizos, V., Astriti, M., Chini, M., Chrysos, G., Marangos, M., Panagopoulos, P., Kofteridis, D., Sambatakou, H., Mastrogianni, E., Panatzis, N., Pechlivanidou, E., Psichοgiou, M., Touloumi, G., & Athens Multicenter AIDS Cohort Study (AMACS) (2024). HCV Cascade of Care in HIV/HCV Co-Infected Individuals: Missed Opportunities for Micro-Elimination. Viruses. https://doi.org/10.3390/v16060885

Vancouver

Thomadakis C, Basoulis D, Tsachouridou O, Protopapas K, Paparizos V, Astriti M, et al. HCV Cascade of Care in HIV/HCV Co-Infected Individuals: Missed Opportunities for Micro-Elimination. Viruses. 2024. doi:10.3390/v16060885

BibTeX
@article{Thomadakis2024,
  author = {Thomadakis, Christos and Basoulis, Dimitrios and Tsachouridou, Olga and Protopapas, Konstantinos and Paparizos, Vasilios and Astriti, Myrto and Chini, Maria and Chrysos, Georgios and Marangos, Markos and Panagopoulos, Periklis and Kofteridis, Diamantis and Sambatakou, Helen and Mastrogianni, Elpida and Panatzis, Nikos and Pechlivanidou, Evmorfia and Psichοgiou, Mina and Touloumi, Giota and Athens Multicenter AIDS Cohort Study (AMACS), Athens Multicenter AIDS Cohort Study (AMACS)},
  title = {HCV Cascade of Care in HIV/HCV Co-Infected Individuals: Missed Opportunities for Micro-Elimination},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16060885}
}
Kostenlos starten →